Tagged with S

Hungary Dr Beata Sperlagh, Deputy Director of the Institute of Experimental Medicine (IEM), shares her insights on the institute’s involvement in research and with the private sector, the key strengths of IEM in the field of neuroscience, and its importance in the region.   The significant economic burden associated with brain…

Opinion Anthony Harrington of global investment banking and asset management firm Alantra outlines why healthcare and consulting communications companies are increasingly attractive targets for private equity.   The supply of PE money chasing fewer and fewer assets is only going to increase the attraction of healthcare communications and consulting firms to…

USA Peter Marks, director of the US FDA’s Center for Biologics Evaluation and Research, outlines how the organization is attempting to further promote the advancement of cutting edge cell and gene therapies in the US and beyond.   To keep pace with the remarkable and continuing growth of gene therapy, FDA’s…

UAE Dr Omar Hallak, head of the cardiovascular department at King’s College Hospital Dubai (KCHD) and president of the Gulf chapter of the International Society of Endovascular Specialists, discusses issues pertaining to cardiovascular disease (CVD) within the UAE, 4TS – a conference founded by Hallak to encourage the sharing of knowledge…

Hungary Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to facilitate ease of business.   For international investors and businesses, the most remarkable reform has been the establishment of a…

Puerto Rico Dr Amarilys Silva-Boschetti and Dr Miguel Vázquez-Padua of the Puerto Rico Consortium for Clinical Investigation (PRCCI) underline the various benefits for pharmaceutical, biotechnology and medtech companies to conduct clinical trials in Puerto Rico. They also highlight further steps of how the Consortium, which is part of the Puerto Rico Science,…

Sweden We recently analysed the contents of 20 interviews conducted with country managers at multinational pharma companies in Sweden and found some underlying words and themes present in the majority of the interviews (see above for the full wordcloud). This is an exclusive glimpse into what is currently at the top…

Brazil Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research throughout Latin America on neglected diseases.   This agreement establishes an exchange of know-how that will provide progress in public health policies in Brazil Patrice Matchaba, global head of corporate responsibility, Novartis…

Czech Republic The Czech Republic is aiming to carve out a space for itself among Europe’s most innovative countries by 2030 as part of the ‘Innovation Strategy of the Czech Republic 2019–2030.’ While a number of promising steps have already been taken, it is far too soon to tell whether the Czechs…

Puerto Rico Jorge Luis Rodriguez, CEO of PACIV, a Puerto Rican provider of industrial automation solutions for the life science’s industry, reveals the three key performance indicators that make the island a global powerhouse for pharma manufacturing. Moreover, he explains the company’s unique one-stop-shop approach and how Puerto Rico has managed to…

Hungary Oliver Strommer, newly appointed executive director of the British Chamber of Commerce in Hungary (BCCH), introduces the Chamber and its refocused aim of becoming a more dynamic player in business connectivity between the two countries. Aside from highlighting the activities of the BCCH, Strommer goes on to offer insights into…

Puerto Rico In June 2019, Sartorius Stedim Biotech inaugurated the USD 130 million expansion of its Yauco site, one of the first multi-million dollar investment projects on the island after Hurricane Maria. Dante Castillo, the Yauco site’s director of operations, explains how this expansion fits within the group’s global ambitions and what…